Literature DB >> 20799259

Weighted Kaplan-Meier estimators for two-stage treatment regimes.

Sachiko Miyahara1, Abdus S Wahed.   

Abstract

In two-stage randomization designs, patients are randomized to one of the initial treatments, and at the end of the first stage, they are randomized to one of the second stage treatments depending on the outcome of the initial treatment. Statistical inference for survival data from these trials uses methods such as marginal mean models and weighted risk set estimates. In this article, we propose two forms of weighted Kaplan-Meier (WKM) estimators based on inverse-probability weighting-one with fixed weights and the other with time-dependent weights. We compare their properties with that of the standard Kaplan-Meier (SKM) estimator, marginal mean model-based (MM) estimator and weighted risk set (WRS) estimator. Simulation study reveals that both forms of weighted Kaplan-Meier estimators are asymptotically unbiased, and provide coverage rates similar to that of MM and WRS estimators. The SKM estimator, however, is biased when the second randomization rates are not the same for the responders and non-responders to initial treatment. The methods described are demonstrated by applying to a leukemia data set.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20799259     DOI: 10.1002/sim.4020

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Sample size formulae for two-stage randomized trials with survival outcomes.

Authors:  Zhiguo Li; Susan A Murphy
Journal:  Biometrika       Date:  2011-07-13       Impact factor: 2.445

2.  Dynamic Treatment Regimes.

Authors:  Bibhas Chakraborty; Susan A Murphy
Journal:  Annu Rev Stat Appl       Date:  2014       Impact factor: 5.810

3.  Inference about the expected performance of a data-driven dynamic treatment regime.

Authors:  Bibhas Chakraborty; Eric B Laber; Ying-Qi Zhao
Journal:  Clin Trials       Date:  2014-06-12       Impact factor: 2.486

4.  Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.

Authors:  Zhiguo Li
Journal:  Stat Med       Date:  2016-09-19       Impact factor: 2.373

5.  Cumulative Hazard Ratio Estimation for Treatment Regimes in Sequentially Randomized Clinical Trials.

Authors:  Xinyu Tang; Abdus S Wahed
Journal:  Stat Biosci       Date:  2015-05

6.  Q-LEARNING WITH CENSORED DATA.

Authors:  Yair Goldberg; Michael R Kosorok
Journal:  Ann Stat       Date:  2012-02-01       Impact factor: 4.028

7.  Targeted maximum likelihood estimation for dynamic treatment regimes in sequentially randomized controlled trials.

Authors:  Paul H Chaffee; Mark J van der Laan
Journal:  Int J Biostat       Date:  2012-06-22       Impact factor: 0.968

8.  A global logrank test for adaptive treatment strategies based on observational studies.

Authors:  Zhiguo Li; Marcia Valenstein; Paul Pfeiffer; Dara Ganoczy
Journal:  Stat Med       Date:  2013-09-20       Impact factor: 2.373

9.  SMART designs in cancer research: Past, present, and future.

Authors:  Kelley M Kidwell
Journal:  Clin Trials       Date:  2014-04-14       Impact factor: 2.486

10.  Timeliness and completeness of measles vaccination among children in rural areas of Guangxi, China: A stratified three-stage cluster survey.

Authors:  Xianyan Tang; Alan Geater; Edward McNeil; Hongxia Zhou; Qiuyun Deng; Aihu Dong
Journal:  J Epidemiol       Date:  2017-02-08       Impact factor: 3.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.